The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate
eLife · 01.06.2023 · 12
DOI: 10.7554/elife.76927 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 01.06.2023. Verfasst von Minato Hirano und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, United States. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Multiple Sclerosis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Genes associated with increased susceptibility to multiple sclerosis (MS) have been identified, but their functions are incompletely understood. One of these genes codes for the RNA helicase DExD/H-Box Polypeptide 39B (DDX39B), which shows genetic and functional epistasis with interleukin-7 receptor-α gene ( IL7R ) in MS-risk. Based on evolutionary and functional arguments, we postulated that DDX39B enhances immune tolerance thereby decreasing MS risk. Consistent with such a role we show that DDX39B controls the expression of many MS susceptibility genes and important immune-related genes. Among these we identified Forkhead Box P3 ( FOXP3 ), which codes for the master transcriptional factor in CD4 + /CD25 + T regulatory cells. DDX39B knockdown led to loss of immune-regulatory and gain of immune-effector expression signatures. Splicing of FOXP3 introns, which belong to a previously unrecognized type of introns with C-rich polypyrimidine tracts, was exquisitely sensitive to DDX39B levels. Given the importance of FOXP3 in autoimmunity, this work cements DDX39B as an important guardian of immune tolerance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, United States.
- National Research Center for the Control and Prevention of Infectious Disease, Nagasaki University, Nagasaki, Japan.
- Autoimmunity Biological Solutions, Galveston, United States.
- Human Pathophysiology and Translational Medicine Program, Institute for Translational Sciences, University of Texas Medical Branch, Galveston, United States.
- Department of Molecular Genetics and Microbiology, Duke University, Durham, United States.
- Duke Molecular Physiology Institute, Duke University, Durham, United States.
ORCID-Profile: Steven G Widen, Dennis C Ko, Shelton Bradrick, Mariano A Garcia-Blanco
Förderung
- NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
- Uehara Foundation
- McLaughlin Family Foundation
Zitieren
APA
Hirano, M., Galarza-Muñoz, G., Nagasawa, C., Schott, G., Wang, L., Antonia, A. L., Jain, V., Yu, X., Widen, S. G., Briggs, F. B. S., Gregory, S. G., Ko, D. C., Fagg, W. S., Bradrick, S., & Garcia-Blanco, M. A. (2023). The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate. eLife, 12. https://doi.org/10.7554/elife.76927
Vancouver
Hirano M, Galarza-Muñoz G, Nagasawa C, Schott G, Wang L, Antonia AL, et al. The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate. eLife. 2023;12. doi:10.7554/elife.76927
BibTeX
@article{Hirano2023,
author = {Hirano, Minato and Galarza-Muñoz, Gaddiel and Nagasawa, Chloe and Schott, Geraldine and Wang, Liuyang and Antonia, Alejandro L and Jain, Vaibhav and Yu, Xiaoying and Widen, Steven G and Briggs, Farren B S and Gregory, Simon G and Ko, Dennis C and Fagg, William S and Bradrick, Shelton and Garcia-Blanco, Mariano A},
title = {The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.76927}
}
EUVIMED